戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 988076作成日:2026年10月25日

(+)-Lariciresinol → (+)-Pinoresinol (+)-Lariciresinol

https://huagongshe.com/reaction/988076

反応式

関与物質

役割名称HCID仕込み量
反応物(+)-LariciresinolHCID 332427—
反応物EpipinoresinolHCID 637584—
溶媒MethanolHCID 887—
生成物(+)-Pinoresinol (+)-LariciresinolHCID 131722472—

反応条件

温度30 °C

反応手順

Enzyme Assays. Pinoresinol and lariciresinol reductase activities were assayed by monitoring the formation of [3H]lariciresinol and [3H]secoisolariciresinol as set forth in Example 8, with the following modifications. Briefly, each assay for pinoresinol reductase activity consisted of (±)-pinoresinols (5 mM in MeOH, 20 μl) and the enzyme preparation (i.e., total protein extract from E. coli, 210 μl). The enzymatic reaction was initiated by addition of [4R-3H]NADPH (10 mM, 6.79 kBq/mmol in distilled H2O, 20 μl). After 3 hour incubation at 30° C. with shaking, the assay mixture was extracted with EtOAc (500 μl) containing (±)-lariciresinols (20 μg) and (±)-secoisolariciresinols (20 μg) as radiochemical carriers. After centrifugation (13,800×g, 5 min), the EtOAc solubles were removed and the extraction procedure was repeated. For each assay, the EtOAc solubles were combined with an aliquot (100 μl) removed for determination of its radioactivity using liquid scintillation counting. The remainder of the combined EtOAc solubles was evaporated to dryness in vacuo, reconstituted in MeOH/H2O (30:70, 100 μl) and subjected to reversed phase and chiral column HPLC.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US06635459B1
出典データセットuspto-grants-2003_10
ORD IDord-3355eda6ba77466bab8234bb86e7bfad
出典メモuspto-grants-2003_10